Indoco Remedies reports Q1 net loss of ₹281 crores

Indoco Remedies reported a consolidated net loss of ₹364 crores for the quarter ending June 30, 2025, compared to total income of ₹438 crores.

The pharmaceutical company's standalone operations showed a net loss of ₹281 crores against income of ₹393 crores. Basic earnings per share stood at ₹(3.94) on a consolidated basis and ₹(3.04) standalone.